| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $2,959,893 | 12 | 100 |
| Multani Pratik S | Chief Medical Officer | 0 | $0 | 1 | $97,129 | $-97,129 |
| Chacko Jacob | PRESIDENT AND CEO | 0 | $0 | 1 | $302,368 | $-302,368 |
| Heyman Richard A. | director | 0 | $0 | 4 | $328,017 | $-328,017 |
| Piscitelli Dominic | Chief Financial Officer | 0 | $0 | 6 | $2.23M | $-2.23M |
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, …
Over the last 12 months, insiders at ORIC Pharmaceuticals, Inc. have bought $0 and sold $2.96M worth of ORIC Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at ORIC Pharmaceuticals, Inc. have bought $841,876 and sold $2.16M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,403 shares for transaction amount of $13,230 was made by You Angie (director) on 2025‑06‑23.
| 2026-10-20 | Sale | Piscitelli Dominic | Chief Financial Officer | 14,000 0.0133% | $13.53 | $189,391 | -32.73% | |
| 2026-10-01 | Sale | Heyman Richard A. | director | 6,700 0.0067% | $12.91 | $86,524 | -4.23% | |
| 2026-09-28 | Sale | Piscitelli Dominic | Chief Financial Officer | 13,400 0.0126% | $13.53 | $181,258 | -9.42% | |
| 2026-09-24 | Sale | Piscitelli Dominic | Chief Financial Officer | 600 0.0006% | $13.50 | $8,103 | -8.04% | |
| 2026-08-26 | Sale | Piscitelli Dominic | Chief Financial Officer | 77,000 0.0732% | $13.69 | $1.05M | -9.17% | |
| 2026-07-24 | Sale | Heyman Richard A. | director | 13,100 0.0126% | $12.02 | $157,462 | +5.70% | |
| 2026-07-06 | Sale | Heyman Richard A. | director | 300 0.0003% | $12.00 | $3,600 | +14.94% | |
| 2026-02-24 | Sale | Piscitelli Dominic | Chief Financial Officer | 52,000 0.0538% | $13.51 | $702,686 | -17.29% | |
| 2026-01-16 | Sale | Heyman Richard A. | director | 6,700 0.0068% | $12.00 | $80,431 | -8.54% | |
| 2025-12-16 | Sale | Chacko Jacob | PRESIDENT AND CEO | 33,374 0.034% | $9.06 | $302,368 | +19.41% | |
| 2025-12-16 | Sale | Multani Pratik S | Chief Medical Officer | 10,720 0.0109% | $9.06 | $97,129 | +19.41% | |
| 2025-12-16 | Sale | Piscitelli Dominic | Chief Financial Officer | 10,720 0.0109% | $9.06 | $97,127 | +19.41% | |
| 2025-10-06 | Sale | Chacko Jacob | PRESIDENT AND CEO | 37,461 0.033% | $12.32 | $461,520 | -22.69% | |
| 2025-10-06 | Sale | Piscitelli Dominic | Chief Financial Officer | 11,000 0.0114% | $14.52 | $159,719 | -22.69% | |
| 2025-10-01 | Sale | Chacko Jacob | PRESIDENT AND CEO | 53,001 0.0548% | $12.05 | $638,805 | -4.87% | |
| 2025-09-30 | Sale | Chacko Jacob | PRESIDENT AND CEO | 34,538 0.0356% | $12.01 | $414,750 | -7.17% | |
| 2025-09-22 | Sale | Chacko Jacob | PRESIDENT AND CEO | 125,000 0.1285% | $10.80 | $1.35M | +2.59% | |
| 2025-07-01 | Sale | Piscitelli Dominic | Chief Financial Officer | 20,000 0.0233% | $10.05 | $200,972 | +5.03% | |
| 2025-06-24 | Sale | Piscitelli Dominic | Chief Financial Officer | 32,466 0.0381% | $10.50 | $341,039 | +1.33% | |
| 2025-06-23 | Sale | Piscitelli Dominic | Chief Financial Officer | 1,034 0.0012% | $10.00 | $10,345 | +6.30% |
| Chacko Jacob | PRESIDENT AND CEO | 581711 0.5612% | $5.58M | 2 | 34 | +18.89% |
| Piscitelli Dominic | Chief Financial Officer | 69828 0.0674% | $669,650.52 | 1 | 18 | <0.0001% |
| ORBIMED ADVISORS LLC | director | 2212571 2.1346% | $21.22M | 1 | 14 | +4.15% |
| GORDON CARL L | director | 2212571 2.1346% | $21.22M | 1 | 14 | +4.15% |
| You Angie | director | 28000 0.027% | $268,520.00 | 2 | 0 | +10.29% |
$831,902,292 | 108 | 9.34% | $1.2B | |
$15,410,062 | 81 | 39.69% | $975.93M | |
$5,911,307 | 70 | -1.38% | $884.8M | |
$11,663,618 | 57 | 32.20% | $934.29M | |
$276,808,393 | 17 | -6.69% | $888.11M |
| Increased Positions | 104 | +73.76% | 19M | +19.23% |
| Decreased Positions | 58 | -41.13% | 6M | -6.25% |
| New Positions | 35 | New | 8M | New |
| Sold Out Positions | 24 | Sold Out | 1M | Sold Out |
| Total Postitions | 187 | +32.62% | 114M | +12.97% |
| Nextech Invest, Ltd. | $58,519.00 | 7.38% | 7.16M | 0 | 0% | 2025-09-30 |
| Ecor1 Capital, Llc | $54,969.00 | 6.94% | 6.73M | +5M | +315.81% | 2025-09-30 |
| Vr Adviser, Llc | $53,897.00 | 6.8% | 6.6M | 0 | 0% | 2025-09-30 |
| Viking Global Investors Lp | $53,699.00 | 6.78% | 6.57M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $43,110.00 | 5.44% | 5.28M | +1M | +29.39% | 2025-09-30 |
| Vanguard Group Inc | $37,992.00 | 4.79% | 4.65M | +2M | +48.82% | 2025-09-30 |
| Sr One Capital Management, Lp | $36,887.00 | 4.66% | 4.51M | 0 | 0% | 2025-09-30 |
| Alkeon Capital Management Llc | $36,798.00 | 4.64% | 4.5M | 0 | 0% | 2025-09-30 |
| Nea Management Company, Llc | $33,649.00 | 4.25% | 4.12M | 0 | 0% | 2025-09-30 |
| Orbimed Advisors Llc | $29,753.00 | 3.75% | 3.64M | +3M | +304.96% | 2025-09-30 |